Wells Fargo & Company ENLIVEN THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024
Number of Shares
11,118
Previous 11,489 3.23%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
N/A
-371 Reduced 3.23%
11,118 $0
Q2 2024

Aug 13, 2024
BUY
N/A
3,274 Added 39.85%
11,489 $0
Q1 2024

May 10, 2024
BUY
N/A
1,057 Added 14.77%
8,215 $0
Q4 2023

Feb 09, 2024
BUY
N/A
1,418 Added 24.7%
7,158 $0
Q3 2023

Nov 13, 2023
SELL
N/A
-3,130 Reduced 35.29%
5,740 $0
Q2 2023

Aug 15, 2023
BUY
N/A
8,846 Added 36858.33%
8,870 $0
Q1 2023

May 12, 2023
BUY
N/A
24 New
24 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email